MIRA INFORM REPORT

 

 

Report Date :           

19.08.2011

 

IDENTIFICATION DETAILS

 

Name :

WINCHEM PHARMACEUTICAL & CHEMICAL COMPANY INC.

 

 

Registered Office :

Dongfang Avenue, Jingzhou Development Zone, Hubei Province , Zip Code 434000

 

 

Country :

China

 

 

Date of Incorporation :

31.05.2010

 

 

Com. Reg. No.:

421000000074403

 

 

Legal Form :

Shares Limited Company

 

 

Line of Business :

Manufacture and sales of chemical raw materials and  medical intermediates

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Usually Correct 

 

 

Litigation :

Clear

 


NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

                   (31.12.2010)                  

Current Rating

(31.03.2011)

China

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name & address 

 

WINCHEM PHARMACEUTICAL & CHEMICAL COMPANY INC.

Dongfang Avenue, Jingzhou Development Zone, Hubei Province

434000

Tel :                        86 716 8303013

Fax                        86 716 8303480

Website                  www.jznengte.com  

   

Currency in this report is Chinese Yuan unless otherwise stated.

 

Exchange Rate: 1 USD=6.55 Chinese Yuan

 

"--"in this report indicates "unavailable" due to insufficient information or "no comments"

 

       

EXECUTIVE SUMMARY

 

DATE OF establishment      : may 31st, 2010

Aic Registration No.            : 421000000074403

REGISTERED LEGAL FORM    : Shares limited co

REGISTERED CAPITAL : 33,850,000.00

main BUSINESS                        : manufacture and sales of chemical raw materials and

 medical intermediates

employees                            : 150

import and export

permits                                  : yes

base CREDIT limit                  : 0

EXCHANGE RATE                     : 1 Usd=6.55 CNY (apr 2nd, 2011)

 

Registered Address:        Dongfang Avenue, Jingzhou Development Zone, Hubei Province , Zip Code 434000

Telephone:                        86 716 13886612222

 

Business Address         Dongfang Avenue, Jingzhou Development Zone, Hubei Province , Zip Code:434000

Telephone:                    86 716 8303013

Fax:                                86 716 8303480

SIC Code (China):     2614 manufacture of organic chemical material

   


REGISTRATION

 

Date of Establishment

May 31st, 2010

Registry

Administration Bureau of Industry and Commerce - Jingzhou

Legal Representative

Chen Liequan

AIC Registration Number

421000000074403

Registered Legal Form

Shares limited co.

Registered Capital

33,850,000.00

Operating Period

From May 31st, 2010 to --

Business Scope

Research, manufacture and sales of new pharmaceutical intermediate technology products (excluding those forbidden by the government), technology service and transfer of related technology. Import and export of goods and technology (excluding those forbidden by the government)

Changes in Registration

May 31st, 2010

Subject’s business scope was changed from

research, manufacture and sales of new pharmaceutical intermediate technology products (excluding those forbidden by the government), technology service and transfer of related technology.

to the present business scope.

 

 

 

Shares limited co.

This form of business in PR China is defined as a legal person. Its registered capital is divided into shares of equal par value and the co. raises capital by issuing share certificates by promotion or by public offer. Shareholders bear limited liability to the extent of shareholding, and the co. is liable for its debts only to the extent of its total assets. The characteristics of the shares limited co. are as follows:

 

The establishment of the co. requires at least five promoters and at least three of them must be PR- China controlled legal persons. Natural person can not be allowed to serve as promoters.

 

The minimum registered capital of a co. is RMB 10M. while that of the co. with foreign investment is RMB 30M. The total capital of a co. which propose to apply for publicly listed must not less than RMB 50M.

 

The board of directors must consist of an odd number of five to nineteen directors.

If the co. raises capital by public offer, the promoters must not subscribe less than 35% of the total shares. the promoters’ shares are restricted to transfer- within three years of the offer. Directors can not transfer the shares they hold in the co. during their terms of office.

 

A state-owned enterprise that is restructured into a shares limited co. must comply with the conditions & requirements specified under the law & administrative rule.              

 

REGISTRATION INFO: AVAILABLE

FINANCIAL REPORTS: AVAILABLE             

                   

FIELD INVESTIGATION

 

1. Subject’s income comes mainly from pharmaceutical raw materials, medical intermediates, chiral compounds. These occupied 80% of its income. Another 20% comes from sales of other special chemicals. Its sales are developed directly to the end users including pharmaceutical and chemical manufacturers. The industry of chemical raw material and medical intermediates is an industry with fierce competition. In addition, SC has only established for a short time. However, as subject’s predecessor (Jingzhou Winchem Pharm.& Chem. Co., Ltd) had developed into  a large development scale and enjoys certain reputation and customer base in the local industry, SC’s competitiveness in the local industry is above average.

2. Jingzhou, where SC is located, is a big city in China. Its high development level provides the local enterprises with wider development space and also many development challenges. As a domestically invested company mainly manufacturing and selling chemical raw materials and medical intermediates, subject shares no favorable policies provided by the local government.

           

SHAREHOLDERS AND SHARES

 

As indicated in the following table:

     

Shareholder

Capital Subscribed

Percentage

Qin Huiling

1,184,700.00

3.5%

    Wang Zhiyuan

2,369,500.00

7.0%

Zhang Wenqi

4,739,000.00

14.0%

Cai Heting

3,554,300.00

10.50%

Chen Liequan

11,221,300.00

33.15%

Yang Zhicheng

10,781,200.00

31.85%

Total

33,850,000.00

100%

     

Shareholder

Way of investment

Paid-up Percentage

Qin Huiling

Entity

100%

Wang Zhiyuan

Entity

100%

Zhang Wenqi

Entity

100%

Cai Heting

Entity

100%

Chen Liequan

Capital

100%

Yang Zhicheng

Capital

100%

        

  Background of major shareholder  

Name

Chen Liequan

Gender

Male

Date of Birth

July 19th, 1963

ID NO.

421081196307190617

 

 

Name

Cai Heting

Gender

Male

Date of Birth

Mar 5th, 1940

ID NO.

320504194003052531

 

 

Name

Yang Zhicheng

Gender

Male

Date of Birth

Jan 25th, 1947

ID NO.

421081194701250615

        

 

MANAGEMENT

 

Name

Chen Liequan

Title

Legal Representative

Gender

Male

ID No.

421081196307190617

Date of birth

July 19th, 1963

        

        

AFFILIATES

 

No affiliate of Subject Company was found after check with the AIC.

 

NUMBER OF EMPLOYEES

 

Employees:                   150

Recent Recruitment    Yes

Recruitment Post:          OA Engineers,

Storage assistant,

Sales Staff,

International trade Assistant,

R&D staff.

 

           

BANKERS INFORMATION

 

Bank Name

Jingzhou Commercial Bank – Yinhai Branch

Account No. for Chinese Yuan

676130100100073983

Telephone of the person investigated

86 716 8124559

Comment

The investigated person confirmed subject opened an account in the above bank. Subject’s daily settlement is normal.

 

OFFICE FACILITIES

 

Geographic Location: SC is located in Dongfang Avenue, Jingzhou Development Zone, Hubei Province .The traffic condition and environment around the premise is good.

 

Property Ownership:                         self-owned

        

        

MAIN PRODUCTS & SERVICES

 

Main business

Manufacture and sales of  chemical raw materials and medical intermediates

Products and services

SC mainly manufactures and sales of  chemical raw materials and medical intermediates. Its main products include lobelines, gliquidones amine, disulfide, boron, etc. It can produce 4,000,000 kg each month. .

           

 

SALES INFORMATION

 

Percentage of domestic sales

80%

Regions

All over China

Major domestic clients

Large pharmaceutical factory

Sales Terms:

Prompt payment; on credit

Percentage of international sales

20%

Regions

USA, India, South Korea, etc.

Sales Terms

L/C , T/T

Subject’s products are mainly sold domestically. Its clients are mainly large pharmaceutical  manufacturers, such as AMERICAN MERCK INC, SIGMA-ALDRICH. INC etc.

The above information was confirmed by SC’s employee

 

 

 PURCHASE INFORMATION

 

Main Commodities Purchased

PH meter, conductivity meter, dissolved oxygen meter, etc.

Number of Major Suppliers

About 5

Major Suppliers

ANHUI SAIKE ENVIRONMENT TECHNOLOGY CO. LTD, CHONG AN CHUANGKE ELECTRICAL EQUIPMENT BUSIESS DEPARTMENT

Main Terms of Payment

Prompt payment; on credit

Subject company’s suppliers are main domestic suppliers. SC now cooperates well with some of its suppliers.

The above information was confirmed by SC’s employee

 

        

CREDIT

 

Name of supplier

ANHUI SAIKE ENVIRONMENT TECHNOLOGY CO. LTD

Main commodities supplied

PH meter, conductivity meter, dissolved oxygen meter, etc

Post of interviewee

Sales staff

Tel

86 551 5281199

Remarks of interviewee

The sales staff of this company confirmed the cooperation relationship with subject and SC’s credit status is normal.

        

           

LITIGATION RECORDS

 

After checking with China court website, local court website and other major searching websites, no litigation records related to subject in the recent 3 years was found.

                       

                       

FINANCE

 

SC was established in May, 2010 and doesn’t reach a financial year. No financial information can be obtained from the AIC. Therefore no financial information and recommended credit limit is provided in this report.

 

                                               

INDUSTRY PROFILE

           

Industry

SIC Code (China): 2614 manufacture of organic chemical material

Description: manufacture of organic intermediate, HC and halogen derivative, alcohol, phenol and the   derivative, ether, ketone, amides, organic phosphate, organic compound, salt etc.

Status Quo & Trend

From January to March 2010, the export value of chemicals of China reached 77.14 billion Chinese Yuan, increasing 29.6% y/y. Export of specific chemical products increased by more than 30%. In H2 2010, the chemical industry was recovered completely. Organic chemical is a branch of basic chemical material industry. In Dec.2009, there were 2570 organic chemical manufacturers in China, and the output of the whole year was 536,794,655 Chinese Yuan, increasing 5.19% y/y.   

           

GENERAL COMMENTS

 

Subject was registered in May 2010. Its main business is manufacture and sales of chemical raw materials and medical intermediates. Despite its short history, SC’s development future is expected to be good due to the strong background of its predecessor Jingzhou Winchem Pharm. & Chem. Co., Ltd.

Financial analysis can’t be provided due to lack of financial information.     

        

           

        


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.61

UK Pound

1

Rs.75.32

Euro

1

Rs.65.68

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.